A recent systematic review suggested that children with GJB2 mutation do not have significantly better prognoses in auditory performance, including speech recognition, when compared with children with either nonsyndromic HL of unknown origin or other genetic causes of HL in the absence of other neurological deficits [16]. This evidence concerns the gene GJB2 and Hodgkins lymphoma.